Cell therapy may present an option for patients with ischemic heart disease to use their own bone marrow cells to repair the damaged areas of their hearts, and may pave the way for future treatment options, according to the ...
Mar 24, 2012
0
0
(Medical Xpress) -- Older patients with lower rates of left ventricular ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction) appear more likely than younger patients to have ...
Aug 9, 2011
0
0
A new study found that using a patient's own bone marrow cells may help repair damaged areas of the heart caused by heart failure, according to research presented today at the American College of Cardiology's 61st Annual ...
Mar 26, 2012
0
0
Women with chronic heart failure survive longer than their male counterparts, according to a large analysis of studies comprising data on more than 40,000 subjects. The analysis represents the largest assessment of gender ...
Mar 8, 2012
0
0
Approval for Jardiance (empagliflozin) has been expanded to reduce the risk for cardiovascular death and hospitalization for heart failure in adults, the U.S. Food and Drug Administration announced Thursday.
Mar 1, 2022
0
18
Dapagliflozin reduces the risk for worsening heart failure or cardiovascular death, regardless of frailty status, according to a study published online April 26 in the Annals of Internal Medicine.
Apr 26, 2022
0
2
Detection of midwall fibrosis (the presence of scar tissue in the middle of the heart muscle wall) via magnetic resonance imaging among patients with nonischemic dilated cardiomyopathy (a condition affecting the heart muscle) ...
Mar 5, 2013
0
0
(HealthDay) -- For younger adults with premature coronary artery disease (CAD), percutaneous coronary intervention (PCI) is associated with excellent short- and long-term outcomes, according to a study published in the June ...
Jun 6, 2012
0
0
Marked sustained improvement in all patients with zero adverse effects. For a phase I clinical trial, these results are the Holy Grail. Yet researchers from the University of Louisville and Brigham and Women's Hospital today ...
Nov 6, 2012
0
0
Cardiac resynchronization therapy with defibrillators (CRT-D) is appropriate for patients who have left ventricular dysfunction and require chronic ventricular pacing, based on the findings of an observational study that ...
Mar 26, 2012
0
0
